Contact us (is on the right)

  1. Company
    1. About
    2. Services
  2. Media
    1. News blog
    2. Meet GCT team
  3. White papers
    1. Region and countries
    2. Therapeutic areas
  4. Services
    1. Site registration
    2. Patient information Center
  5. Website information
    1. Privacy policy
    2. Terms of service
    3. Site map
    4. Employees login

Get in touch

Call us:

Email: info@gctrials.com

Meet us at upcoming industry events

More: Offices, Career at GCT

Patients: Patient information Center

We are a global CRO Contract Research Organization
with 17 years expertise in clinical trials
in the United States, Central and Eastern Europe,
Russia and India


FDA/EMEA/GCP compliant clinical trials in all therapeutic areas, phases I-IV

Headquarters in Princeton, NJ, USA

Seven regional offices covering Bulgaria, Czech Republic, Hungary, Moldova, Poland,
Romania, Russia, Slovakia, Ukraine and India

Explore coverage details

Head office, BD office
Princeton, NJ, USA

Phone: 1-609-921-6868
Contact details

Russian office, BD office in St. Petersburg

Phone: 7-812-703-0008
Country information
Contact details

Ukrainian office in Kiev

Phone: 38-044-501-9038
Country information
Contact details

Romanian office in Bucharest

Phone: 40-21-527-0380
Country information
Contact details

Bulgarian office in Sofia

Phone: 359-2-983-5358
Country information
Contact details

Central Europe office in Budapest

Phone: 36-30-353-7538
Hungary information
Czech Republic information
Slovakia information
Contact details

A full-service CRO

We will have you covered end-to-end throughout the trial

  • Study start-up
  • Regulatory services
  • Global, regional, local project management
  • Local safety, medical monitoring support
  • Clinical monitoring
  • Patient recruitment
  • Drug logistics
  • Data management and biostatistics
See a detailed list of our services

In the news

See all news

June 22, 2018

Chris Matheus joins GCT

GCT BD team has been enriched and we are happy to announce that Chris Matheus joined us to enhance GCT brand recognition as a global clinical CRO.

“I know Chris for several years now and it is to my great pleasure to welcome him to GCT Team. His expertise is very much valued and professional attitude is fully aligned with ours, therefore, we look forward to working together building new successful relationships within the industry,” comments Dr. Eugene Selivra, Chief Executive Officer of GCT.”

June 04, 2018

Enrollment commences in Phase II Age-Related Macular Degeneration program in EU

GCT has worked closely with the Sponsor on reaching this important milestone and over the past months has secured Regulatory and EC approvals, conducted site initiation visits and managed shipments of required supplies to the sites. We have successfully progressed to the enrollment start on schedule in the two participating countries – Hungary and Poland.

May 17, 2018

Approval received by GCT for an international Phase III cardiac surgery study

GCT is delighted to announce that the approval for an international double-blind Phase III cardiac surgery study was granted by the Russian Ministry of Health.

We manage the Russian part of the clinical trial that will be performed by a dedicated team of Investigators at the leading Cardiology Institute. Our team is responsible for regulatory, clinical and drug logistics services.

 

Meet us at the events

See a full list of the upcoming events

CPhI Middle East & Africa

ADNEC
Abu Dhabi, UAE
September 3-5

Alzheimersmeet

Hyatt Regency
Dubai, UAE
2018, September 6—7

NLSDays

Stockholm Waterfront
Stockholm, Sweden
2018, September 10—12

BioTechMed

Grand Hotel Kempinski
Gelendzhik, Russia
2018, September 17—18

Meet GCT team

Hear our clients

The management team and the CRAs are physicians, and the lead monitor for our breast cancer trial is an oncologist. The monitoring and reporting of the data are exceptional.

Senior Director, Clinical Operations,
US Pharma